Cognitive Behavioral Therapy for Insomnia Linked to Slower Aging in Older Adults
A randomized controlled trial has revealed that cognitive behavioral therapy for insomnia (CBT-I) may be linked to a slower pace of biological aging among older adults. The study, which involved 92 participants aged 60 and older, compared the effects of CBT-I with sleep education therapy (SET) over a period of approximately two years. Researchers utilized three different measures of biological aging: DunedinPACE, GrimAge, and PhenoAge. The results indicated that the CBT-I group experienced a significantly slower pace of biological aging according to the DunedinPACE measure compared to the SET group. However, no statistically significant differences were observed between the two groups on the GrimAge and PhenoAge metrics.
In addition to the biological aging findings, CBT-I was associated with higher rates of insomnia remission. Approximately one-third of participants in the CBT-I group no longer met the criteria for chronic insomnia by the end of the study, compared to only 13 percent in the SET group. Researchers emphasized that while these findings are promising, they should be interpreted as encouraging signals rather than definitive proof that treating insomnia directly slows aging in all biological respects.
The study's design as a randomized controlled trial allowed for a more robust examination of the relationship between insomnia treatment and biological aging over time, rather than merely observing correlations. Chronic insomnia, which affects nearly 60 million Americans, has been linked to various health issues, including cardiovascular problems, cognitive decline, and increased mortality risk. Therefore, the implications of effective insomnia treatment extend beyond sleep quality to potentially influencing overall health and longevity.
The researchers noted that while the DunedinPACE finding is significant, further studies are necessary to validate these results and to explore whether changes in biological aging could lead to improvements in healthspan or lifespan. Sleep specialists advocate for CBT-I as a first-line treatment for chronic insomnia, highlighting its focus on addressing the thoughts and behaviors that contribute to sleep difficulties.
The findings contribute to a growing body of research that underscores the importance of sleep in overall health. Previous studies have shown connections between sleep disruption and various health conditions, including psychiatric disorders and cognitive impairments. The study authors recommend that chronic insomnia be treated regardless of its potential longevity benefits, and they encourage individuals to consider CBT-I as a viable option for managing their sleep issues. Practical steps for those interested in CBT-I include consulting with a healthcare provider and maintaining a sleep diary to track patterns and behaviors that may affect sleep quality.




